Highlights on U.S. FDA-approved halogen-containing drugs in 2024. [PDF]
Ali S, Tian X, Meccia SA, Zhou J.
europepmc +1 more source
Approaches for the detection and analysis of antidrug antibodies to biopharmaceuticals: A review. [PDF]
Suh K, Kyei I, Hage DS.
europepmc +1 more source
Scavenger receptor BI promotes cytoplasmic accumulation of lipoproteins in clear-cell renal cell carcinoma. [PDF]
Velagapudi S +6 more
europepmc +1 more source
Targeting the EphA2 pathway: could it be the way for bone sarcomas? [PDF]
Giordano G +4 more
europepmc +1 more source
New Insights into Drug Development via the Nose-to-Brain Pathway: Exemplification Through Dodecyl Creatine Ester for Neuronal Disorders. [PDF]
Benech H +4 more
europepmc +1 more source
Kidney-targeted nanoplatforms: Strategies and applications. [PDF]
Deng Y +5 more
europepmc +1 more source
Robust increases in erythropoietin production by the hypoxic fetus is a response to protect the brain and other vital organs. [PDF]
Teramo KA, Klemetti MM, Widness JA.
europepmc +1 more source
Effects of recombinant human erythropoietin in the cuprizone mouse model of de- and remyelination
Hagemeyer, N.
core
Analysis of anemia and iron supplementation among glioblastoma patients reveals sex-biased association between anemia and survival. [PDF]
Shenoy G +12 more
europepmc +1 more source
Pharmacokinetics of PEGylated Recombinant Human Erythropoietin in Rats. [PDF]
Cao X, Chen Z, Yu Z, Ge Y, Zeng X.
europepmc +1 more source

